## ANG LI

| | Title| Assistant Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| One Baylor Plaza  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=F6U3r0nOcqv3RYKj5X%2fX&rnd=51baefff-2bda-4cdb-8c5c-d191daa57dad)  
ORCID ![ORCID
Icon](https://profiles.viictr.org/Framework/Images/orcid_16x16\(1\).gif)|
[0000-0002-8455-2309](http://sandbox.orcid.org/0000-0002-8455-2309)
[![Additional
info](https://profiles.viictr.org/Framework/Images/info.png)](https://profiles.viictr.org/about/default.aspx?tab=orcid)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=29964662)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=29964662&cachekey=bd845167-e62d-4be6-a5cd-0172ae9a5d13)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Biography  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
education and training

Northwestern University, Evanston, IL| BA| 06/2007| Biological Sciences  
---|---|---|---  
Baylor College of Medicine, Houston, TX| MD| 05/2012| Medicine  
Massachusetts General Hospital, Boston, MA| Residency| 06/2015| Internal
Medicine  
University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA|
Fellowship| 06/2018| Hematology & Oncology  
University of Washington, Seattle, WA| MS| 03/2019| Epidemiology  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
awards and honors

2007| Phi Beta Kappa Honor Society Centennial Prize  
---|---  
2007| Fulbright Research Scholar in Science and Public Health in Spain  
2012| Gold Humanism Honor Society (GHHS)  
2012| Alpha Omega Alpha (AOA) Honor Society  
2014| ASH Hematology Opportunities for Next Generation of Research Scientists
(HONORS) Award  
2017| ASH Clinical Research Training Institute (CRTI)  
2018| American Society of Hematology (ASH) Abstract Achievement Award  
2019| Hemostasis & Thrombosis Research Society (HTRS) Abstract Achievement
Award  
2019| UW Department of Medicine Chair of Medicine Scholars Award  
2020| ClinGen Variant Curation Expert Panel (VCEP) Member  
2020| Research and Practice in Thrombosis and Haemostasis (RPTH) Editorial
Board Member  
2022| Hematology the ASH Education Program Special Section Editor  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Overview  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
overview

Dr. Li is a non-malignant hematologist who specializes in the care of patients
with congenital and acquired coagulation disorders. He is a physician
scientist who focuses on the prevention and treatment of venous
thromboembolism (VTE) and thrombotic microangiopathy (TMA) in cancer patients
receiving systemic therapy or undergoing hematopoietic cell transplantation
(HCT). He is experienced in conducting clinical epidemiology and health
services research using "big data", ranging from administrative claims
database from public and private payers, to electronic health records (EHR)
from multiple US hospital systems. He has achieved linkage of
clinical/research data among the hospital/regional cancer registry, EHR data
warehouse, biobanking repository, and GWAS databases. Dr. Li's group
collaborates extensively with researchers in the fields of clinical
epidemiology, health economics, clinical informatics, statistical genetics,
and translational science, with an ultimate goal to optimally utilize big data
arising from EHR toward risk factor/outcome association and prediction for
cancer patients in the longitudinal setting.  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
keywords

  * [Venous Thromboembolism](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=Venous Thromboembolism&exactphrase=false)
  * [Thrombosis, Venous](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=Thrombosis, Venous&exactphrase=false)
  * [Thrombotic Microangiopathy](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=Thrombotic Microangiopathy&exactphrase=false)
  * [Thrombotic Thrombocytopenic Purpura](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=Thrombotic Thrombocytopenic Purpura&exactphrase=false)
  * [Factor Xa Inhibitors](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=Factor Xa Inhibitors&exactphrase=false)
  * [Neoplasm](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=Neoplasm&exactphrase=false)

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Research  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
research activities and funding

ASH Scholar Award in Clinical Research (Ang Li)Jul 1, 2024 - Jun 30,
2027American Society of Hematology  
Assessing Bleeding and Thrombosis Risk in People with Cancer using Clinical
Informatics  
Role Description: The major goals are to create a validated phenotype for
clinically relevant bleeding using natural language processing incorporating
large language models, and to derive an optimal risk prediction model for
bleeding using available clinical and biomarker data.  
Role: PI  
---  
  
* * *  
  
3OT2OD032581-01S1 (RF00280-SUB00302) (Vishwanatha, Jamboor)Sep 17, 2023 - Sep
16, 2025NIH/AIM-AHEAD  
Utilizing ethical artificial intelligence/machine learning (AI/ML) to assess
and address disparity in underserved cancer patients across multiple
healthcare systems with diverse social determinants of health  
Role Description: The major goals are to develop AI tools incorporating both
ML-based natural language processing (NLP) and rule-based algorithms to create
validated computable phenotypes for real-world data in heterogenous cancer
patients enriched for racial/ethnic minorities, build optimized clinical risk
prediction models for heterogeneous cancer patients that follow algorithmic
fairness principles to create actionable knowledge, and test patient centered
clinical decision support (PC-CDS) EHR tools.  
Role: Site MPI  
  
* * *  
  
3OT2-OD032581 01S1 (RF00280-SUB00152) (Vishwanatha, Jamboor)Sep 17, 2022 - Sep
16, 2023NIH/AIM-AHEAD  
Building AI/ML algorithm to predict and prevent cancer treatment complications
in underserved and minority patients in a metropolitan catchment area  
Role Description: The goal of this study is to use a cancer registry-linked
electronic health record (EHR) database to test AI/ML algorithms in predicting
cancer therapy related complications in ~18,000 underserved and minority
patients with newly diagnosed cancer.  
Role: Site MPI  
  
* * *  
  
K23HL159271 (Ang Li)Apr 1, 2022 - Mar 31, 2027NIH/NHLBI  
Epidemiology and Biomarkers in Transplant Associated Thrombotic
Microangiopathy (TA-TMA): A Prospective Validation Cohort Study  
Role Description: The goals are to prospectively assess the incidence of TA-
TMA in a large pediatric cohort and to test a dynamic risk prediction tool
that incorporates validated clinical and laboratory biomarkers in immune,
endothelial, and complement activation pathways.  
Role: PI  
  
* * *  
  
6NU38OT000280-03-02 (Neil Zakai)Sep 1, 2020 - Jul 31, 2022CDC  
Understanding risk factors and burden of COVID-19 related thrombosis and
bleeding complications  
Role Description: The goals are to determine the incidence of thrombosis and
bleeding and to assess benefit/harm of therapeutic anticoagulation among
hospitalized patients with COVID-19 across 9 different hospital systems with
over 10,000 patients.  
Role: Site PI  
  
* * *  
  
RR190104 (Ang Li)Aug 31, 2019 - Aug 30, 2024Cancer Prevention & Research
Institute of Texas (CPRIT)  
Role Description: The goal of this project is to study the epidemiology and
prevention of cancer-associated thrombosis and to determine the patient and
societal impact of a thromboprophylaxis program.  
Role: PI  
  
* * *  
  
Mentored Research Award (Ang Li)Jan 1, 2019 - Dec 31, 2020Hemostasis and
Thrombosis Research Society (HTRS)  
Role Description: The goal of this project is to study the incidence and risk
factors for patients with transplant-associated thrombotic microangiopathy
using the institutional database.  
Role: PI  
  
* * *  
  
NHF-Shire Clinical Fellowship (Ang Li)Jan 1, 2019 - Dec 31, 2019National
Hemophilia Foundation (NHF)  
Role Description: The goal of this grant is to support the dedicated clinical
and research training in thrombosis and hemostasis.  
  
* * *  
  
Young Investigator Award (Ang Li)Jan 1, 2019 - Dec 31, 2019Conquer Cancer
Foundation (CCF)  
Role Description: The goal of this project is to study the incidence of and
risk factors for venous thromboembolism in high-risk multiple myeloma patients
by using the SEER-Medicare database.  
Role: PI  
  
* * *  
  
T32HL007093 (ABKOWITZ, JANIS L)Jul 1, 1975 - Jun 30, 2020NIH  
HEMATOLOGY TRAINING  
Role: Research Fellow  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Kim RB, Zhou E, Swinnerton KN, La J, [Ma S](https://profiles.viictr.org/profile/39339169), Ranjan M, Do NV, Brophy MT, Fillmore NR, **Li A**. Racial and Ethnic Disparity for Cancer Mortality in General and Single-Payer Healthcare Systems in the United States. J Racial Ethn Health Disparities. 2024 Jul 02. PMID: [38955957](//www.ncbi.nlm.nih.gov/pubmed/38955957).

Citations:  Fields:

Epi EpidemiologyPub Public HealthSoc Social Sciences

  2. [Ma S](https://profiles.viictr.org/profile/39339169), La J, Swinnerton KN, Guffey D, Bandyo R, De Las Pozas G, Hanzelka K, Xiao X, Rojas-Hernandez CM, [Amos CI](https://profiles.viictr.org/profile/23372697), Chitalia V, Ravid K, Merriman KW, Flowers CR, Fillmore N, **Li A**. Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study. Am J Hematol. 2024 Jul; 99(7):1230-1239. PMID: [38654461](//www.ncbi.nlm.nih.gov/pubmed/38654461); PMCID: [PMC11166507](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11166507).

Citations:  Fields:

Hem Hematology

Translation:Humans

  3. Lee M, [Jiang JY](https://profiles.viictr.org/profile/49466804), Nze C, Guffey D, Kim R, [Oluyomi AO](https://profiles.viictr.org/profile/21983659), Rosales O, Bandyo R, [Miller-Chism CN](https://profiles.viictr.org/profile/3494080), [Udden MM](https://profiles.viictr.org/profile/266554), Mims MP, [Ma H](https://profiles.viictr.org/profile/18883253), Rivero GA, [Diamond A](https://profiles.viictr.org/profile/31721883), [Teegavarapu PS](https://profiles.viictr.org/profile/23478762), Flowers CR, **Li A** , Alam ST. HSR24-130: Real-World Outcomes in Patients With Burkitt Lymphoma in a Safety-Net Health System. J Natl Compr Canc Netw. 2024 Apr 05; 22(2.5). PMID: [38579838](//www.ncbi.nlm.nih.gov/pubmed/38579838).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  4. Shang H, [Jiang JY](https://profiles.viictr.org/profile/49466804), Guffey D, Novoa F, Bandyo R, [Ma S](https://profiles.viictr.org/profile/39339169), **Li A**. Natural history of cancer-associated splanchnic vein thrombosis. J Thromb Haemost. 2024 May; 22(5):1421-1432. PMID: [38309433](//www.ncbi.nlm.nih.gov/pubmed/38309433); PMCID: [PMC11138146](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11138146).

Citations:  Fields:

Hem Hematology

  5. Zakai NA, Wilkinson K, Sparks AD, Packer RT, Koh I, Roetker NS, Repp AB, Thomas R, Holmes CE, Cushman M, Plante TB, Al-Samkari H, Pishko AM, Wood WA, Masias C, Gangaraju R, **Li A** , Garcia D, Wiggins KL, Schaefer JK, Hooper C, Smith NL, McClure LA. Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study. J Thromb Haemost. 2024 Feb; 22(2):503-515. PMID: [37918635](//www.ncbi.nlm.nih.gov/pubmed/37918635); PMCID: [PMC10872863](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10872863).

Citations:  Fields:

Hem Hematology

Translation:Humans

  6. [Ma S](https://profiles.viictr.org/profile/39339169), [Bhar S](https://profiles.viictr.org/profile/3009970), Guffey D, Kim RB, Jamil M, [Amos CI](https://profiles.viictr.org/profile/23372697), Lee SJ, Hingorani SR, [Sartain SE](https://profiles.viictr.org/profile/3009824), **Li A**. Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy. Transplant Cell Ther. 2023 Nov; 29(11):685.e1-685.e7. PMID: [37597686](//www.ncbi.nlm.nih.gov/pubmed/37597686); PMCID: [PMC11037887](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11037887).

Citations:  Fields:

Hem HematologyTra Transplantation

Translation:Humans

  7. Avery J, Guffey D, Ma S, Basom R, Lee SJ, Garcia D, Rojas Hernandez CM, **Li A** , Martens KL. Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation. Thromb Res. 2023 09; 229:1-6. PMID: [37356171](//www.ncbi.nlm.nih.gov/pubmed/37356171); PMCID: [PMC10527315](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10527315).

Citations:  Fields:

Vas Vascular Diseases

Translation:Humans

  8. Martens KL, **Li A** , La J, May SB, Swinnerton KN, Tosi H, Elbers DC, Do NV, Brophy MT, Gaziano JM, Lotfollahzadeh S, Chitalia V, Ravid K, Fillmore NR. Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care System. JAMA Netw Open. 2023 06 01; 6(6):e2317945. PMID: [37306999](//www.ncbi.nlm.nih.gov/pubmed/37306999); PMCID: [PMC10261992](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10261992).

Citations:  Fields:

Med Medicine (General)

Translation:Humans

  9. **Li A** , May SB, La J, Martens KL, [Amos CI](https://profiles.viictr.org/profile/23372697), Flowers CR, Do NV, Brophy MT, Chitalia V, Ravid K, Gaziano JM, Fillmore NR. Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy. Am J Hematol. 2023 08; 98(8):1214-1222. PMID: [37161855](//www.ncbi.nlm.nih.gov/pubmed/37161855); PMCID: [PMC10569448](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10569448).

Citations:  Fields:

Hem Hematology

Translation:Humans

  10. Thomas RM, Wilkinson K, Koh I, **Li A** , Warren JSA, Roetker NS, Smith NL, Holmes CE, Plante TB, Repp AB, Cushman M, Zakai NA. Development of a computable phenotype using electronic health records for venous thromboembolism in medical inpatients: the Medical Inpatient Thrombosis and Hemostasis study. Res Pract Thromb Haemost. 2023 May; 7(4):100162. PMID: [37342252](//www.ncbi.nlm.nih.gov/pubmed/37342252); PMCID: [PMC10277582](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10277582).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37342252/citedby/)

  11. **Li A** , De Las Pozas G, Andersen CR, Nze CC, Toale KM, Milner EM, Fillmore NR, Chiao EY, [Rojas Hernandez C](https://profiles.viictr.org/profile/17440088), [Kroll MH](https://profiles.viictr.org/profile/12583132), Merriman KW, Flowers CR. External validation of a novel electronic risk score for cancer-associated thrombosis in a comprehensive cancer center. Am J Hematol. 2023 07; 98(7):1052-1057. PMID: [37067102](//www.ncbi.nlm.nih.gov/pubmed/37067102); PMCID: [PMC10330124](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10330124).

Citations:  Fields:

Hem Hematology

Translation:Humans

  12. Zhang Z, Hong W, Wu Q, Tsavachidis S, Li JR, [Amos CI](https://profiles.viictr.org/profile/23372697), Cheng C, [Sartain SE](https://profiles.viictr.org/profile/3009824), [Afshar-Kharghan V](https://profiles.viictr.org/profile/12583895), Dong JF, Bhatraju P, Martin PJ, Makar RS, Bendapudi PK, **Li A**. Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA). Thromb Res. 2023 05; 225:39-46. PMID: [36948020](//www.ncbi.nlm.nih.gov/pubmed/36948020); PMCID: [PMC10147584](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10147584).

Citations:  Fields:

Vas Vascular Diseases

Translation:HumansCells

  13. **Li A** , La J, May SB, Guffey D, da Costa WL, [Amos CI](https://profiles.viictr.org/profile/23372697), Bandyo R, Milner EM, Kurian KM, Chen DCR, Do NV, Granada C, Riaz N, Brophy MT, Chitalia V, Gaziano JM, Garcia DA, Carrier M, Flowers CR, Zakai NA, Fillmore NR. Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems. J Clin Oncol. 2023 06 01; 41(16):2926-2938. PMID: [36626707](//www.ncbi.nlm.nih.gov/pubmed/36626707); PMCID: [PMC10431461](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10431461).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36626707/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  14. Dima D, **Li A** , Granat LM, Dhillon P, Chamseddine F, Yalamanchali A, Mirzai S, Wei W, Samaras CJ, Valent J, Anwer F, Khouri J. External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs. Br J Haematol. 2023 04; 201(2):280-284. PMID: [36604838](//www.ncbi.nlm.nih.gov/pubmed/36604838).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36604838/citedby/) Fields:

Hem Hematology

Translation:Humans

  15. da Costa WL, Guffey D, [Oluyomi A](https://profiles.viictr.org/profile/21983659), Bandyo R, Rosales O, Wallace CD, Granada C, Riaz N, Fitzgerald M, Garcia DA, Carrier M, [Amos CI](https://profiles.viictr.org/profile/23372697), Flowers CR, **Li A**. Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations. Am J Hematol. 2022 08; 97(8):1044-1054. PMID: [35638475](//www.ncbi.nlm.nih.gov/pubmed/35638475).

Citations:  Fields:

Hem Hematology

Translation:Humans

  16. **Li A** , da Costa WL, Guffey D, Milner EM, Allam AK, Kurian KM, Novoa FJ, Poche MD, Bandyo R, Granada C, Wallace CD, Zakai NA, [Amos CI](https://profiles.viictr.org/profile/23372697). Developing and optimizing a computable phenotype for incident venous thromboembolism in a longitudinal cohort of patients with cancer. Res Pract Thromb Haemost. 2022 May; 6(4):e12733. PMID: [35647478](//www.ncbi.nlm.nih.gov/pubmed/35647478); PMCID: [PMC9130880](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9130880).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35647478/citedby/)

  17. **Li A** , Martens KL, Nguyen D, Basom R, [Rondon G](https://profiles.viictr.org/profile/12583296), Jin S, Young E, [Amos CI](https://profiles.viictr.org/profile/23372697), Lee SJ, Davis C, Garcia DA, [Champlin R](https://profiles.viictr.org/profile/12582508), [Shpall E](https://profiles.viictr.org/profile/12582631), [Kebriaei P](https://profiles.viictr.org/profile/12582909), [Rojas Hernandez C](https://profiles.viictr.org/profile/17440088). External validation of the HIGH-2-LOW model: A predictive score for venous thromboembolism after allogeneic transplant. Am J Hematol. 2022 06 01; 97(6):740-748. PMID: [35266218](//www.ncbi.nlm.nih.gov/pubmed/35266218).

Citations:  Fields:

Hem Hematology

Translation:Humans

  18. Van Benschoten V, Roy C, Gupta R, Ouellette L, Hingorani S, **Li A**. Incidence and Risk Factors of Transplantation-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis. Transplant Cell Ther. 2022 05; 28(5):266.e1-266.e8. PMID: [35042011](//www.ncbi.nlm.nih.gov/pubmed/35042011).

Citations:  Fields:

Hem HematologyTra Transplantation

Translation:Humans

  19. Hong W, **Li A** , [Liu Y](https://profiles.viictr.org/profile/268526), Xiao X, Christiani DC, Hung RJ, McKay J, Field J, [Amos CI](https://profiles.viictr.org/profile/23372697), Cheng C. Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. Cancer Res. 2022 01 15; 82(2):199-209. PMID: [34815255](//www.ncbi.nlm.nih.gov/pubmed/34815255); PMCID: [PMC8815061](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8815061).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  20. **Li A** , Kuderer NM, Hsu CY, Shyr Y, Warner JL, [Shah DP](https://profiles.viictr.org/profile/17439980), Kumar V, Shah S, Kulkarni AA, Fu J, Gulati S, Zon RL, Li M, Desai A, Egan PC, Bakouny Z, Kc D, Hwang C, Akpan IJ, McKay RR, Girard J, Schmidt AL, Halmos B, Thompson MA, Patel JM, Pennell NA, Peters S, Elshoury A, de Lima Lopes G, Stover DG, Grivas P, Rini BI, Painter CA, Mishra S, Connors JM, Lyman GH, Rosovsky RP, CCC19 consortium. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19. J Thromb Haemost. 2021 10; 19(10):2522-2532. PMID: [34260813](//www.ncbi.nlm.nih.gov/pubmed/34260813); PMCID: [PMC8420489](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8420489).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34260813/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  21. Chen N, [Jotwani A](https://profiles.viictr.org/profile/23478807), **Li A**. Care Delivery in Cancer Patients With Asymptomatic COVID-19 Infection in a Tertiary, Safety-Net Hospital in Houston, Texas. Am J Clin Oncol. 2021 08 01; 44(8):409-412. PMID: [34107500](//www.ncbi.nlm.nih.gov/pubmed/34107500); PMCID: [PMC8297475](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8297475).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  22. **Li A** , Gupta R, [Amos CI](https://profiles.viictr.org/profile/23372697), Davis C, Pao E, Lee SJ, Hingorani SR. Thrombotic Microangiopathy Increases the Risk of Chronic Kidney Disease but Not Overall Mortality in Long-term Transplant Survivors. Transplant Cell Ther. 2021 10; 27(10):864.e1-864.e5. PMID: [34217847](//www.ncbi.nlm.nih.gov/pubmed/34217847).

Citations:  Fields:

Hem HematologyTra Transplantation

Translation:Humans

  23. Martens KL, [Amos CI](https://profiles.viictr.org/profile/23372697), Hernandez CR, [Kebriaei P](https://profiles.viictr.org/profile/12582909), da Costa WL, Basom R, Davis C, Kesten M, Carrier M, Garcia DA, Lee SJ, **Li A**. Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation. Am J Hematol. 2021 09 01; 96(9):1137-1146. PMID: [34097772](//www.ncbi.nlm.nih.gov/pubmed/34097772).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34097772/citedby/) Fields:

Hem Hematology

Translation:HumansPHPublic Health

  24. [Razjouyan J](https://profiles.viictr.org/profile/15619488), Helmer DA, **Li A** , Naik AD, [Amos CI](https://profiles.viictr.org/profile/23372697), [Bandi V](https://profiles.viictr.org/profile/266259), [Sharafkhaneh A](https://profiles.viictr.org/profile/267036). Differences in COVID-19-Related Testing and Healthcare Utilization by Race and Ethnicity in the Veterans Health Administration. J Racial Ethn Health Disparities. 2022 Apr; 9(2):519-526. PMID: [33694124](//www.ncbi.nlm.nih.gov/pubmed/33694124); PMCID: [PMC7945621](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7945621).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33694124/citedby/) Fields:

Epi EpidemiologyPub Public HealthSoc Social Sciences

Translation:HumansCells

  25. Lindquist I, Olson SR, **Li A** , Al-Samkari H, Jou JH, McCarty OJT, Shatzel JJ. The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis. Platelets. 2022 Jan 02; 33(1):66-72. PMID: [33459573](//www.ncbi.nlm.nih.gov/pubmed/33459573); PMCID: [PMC8286270](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8286270).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33459573/citedby/) Fields:

Hem Hematology

Translation:Humans

  26. Martens KL, da Costa WL, [Amos CI](https://profiles.viictr.org/profile/23372697), Davis C, Kesten M, Lee SJ, Zakai NA, Garcia DA, **Li A**. HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment. Blood Adv. 2021 01 12; 5(1):167-175. PMID: [33570631](//www.ncbi.nlm.nih.gov/pubmed/33570631); PMCID: [PMC7805312](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7805312).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33570631/citedby/) Fields:

Hem Hematology

Translation:Humans

  27. Khaki AR, **Li A** , Diamantopoulos LN, Miller NJ, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin V, Park J, Alva A, Bilen MA, Stewart T, Santos V, Agarwal N, Jain J, Zakharia Y, Devitt M, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P, Morales-Barrera R, Fr?be A. A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors. Eur Urol Oncol. 2021 06; 4(3):464-472. PMID: [33423945](//www.ncbi.nlm.nih.gov/pubmed/33423945); PMCID: [PMC8169524](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8169524).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33423945/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:Humans

  28. Desai A, Gupta R, Advani S, Ouellette L, Kuderer NM, Lyman GH, **Li A**. Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta-analysis of cohort studies. Cancer. 2021 05 01; 127(9):1459-1468. PMID: [33378122](//www.ncbi.nlm.nih.gov/pubmed/33378122).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33378122/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsPHPublic Health

  29. **Li A** , Bhatraju PK, Chen J, Chung DW, Hilton T, Houck K, Pao E, Weiss NS, Lee SJ, Davis C, Schmidt MJ, Lopez JA, Liles WC, Dong JF, Hingorani SR. Prognostic Biomarkers for Thrombotic Microangiopathy after Acute Graft-versus-Host Disease: A Nested Case-Control Study. Transplant Cell Ther. 2021 04; 27(4):308.e1-308.e8. PMID: [33836868](//www.ncbi.nlm.nih.gov/pubmed/33836868); PMCID: [PMC10122917](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10122917).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33836868/citedby/) Fields:

Hem HematologyTra Transplantation

Translation:Humans

  30. **Li A** , Kremer Hovinga JA. Laboratory surveillance of immune-mediated thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):82-84. PMID: [33275690](//www.ncbi.nlm.nih.gov/pubmed/33275690); PMCID: [PMC7727562](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7727562).

Citations:  Fields:

Hem Hematology

Translation:Humans

  31. Schoen MW, Carson KR, Luo S, Gage BF, **Li A** , Afzal A, Sanfilippo KM. Venous thromboembolism in multiple myeloma is associated with increased mortality. Res Pract Thromb Haemost. 2020 Oct; 4(7):1203-1210. PMID: [33134785](//www.ncbi.nlm.nih.gov/pubmed/33134785); PMCID: [PMC7590313](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7590313).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33134785/citedby/)

  32. Epperla N, **Li A** , Logan B, Fretham C, Chhabra S, Aljurf M, Chee L, Copelan E, Hematti P, Lazarus HM, Litzow M, Nishihori T, Olsson RF, Prestidge T, Saber W, Wirk B, Yared JA, Loren A, Pasquini M, Freytes CO. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy. Br J Haematol. 2020 06; 189(6):1171-1181. PMID: [32124435](//www.ncbi.nlm.nih.gov/pubmed/32124435); PMCID: [PMC7726817](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7726817).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32124435/citedby/) Fields:

Hem Hematology

Translation:HumansCTClinical Trials

  33. Colling M, Sun L, Upadhyay V, Ryu J, **Li A** , Uhl L, Kaufman RM, Stowell CP, Dzik WH, Makar RS, Bendapudi PK. Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpura. Transfusion. 2020 04; 60(4):841-846. PMID: [32080877](//www.ncbi.nlm.nih.gov/pubmed/32080877).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32080877/citedby/) Fields:

Hem Hematology

Translation:Humans

  34. **Li A** , Carlson JJ, Kuderer NM, Schaefer JK, Li S, Garcia DA, Khorana AA, Carrier M, Lyman GH. Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States. Cancer. 2020 04 15; 126(8):1736-1748. PMID: [31999844](//www.ncbi.nlm.nih.gov/pubmed/31999844).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31999844/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  35. Martens KL, Khalighi PR, Li S, White AA, Silgard E, Frieze D, Estey E, Garcia DA, Hingorani S, **Li A**. Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia. Leuk Res. 2020 02; 89:106298. PMID: [31945598](//www.ncbi.nlm.nih.gov/pubmed/31945598).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31945598/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  36. Khaki AR, **Li A** , Diamantopoulos LN, Bilen MA, Santos V, Esther J, Morales-Barrera R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Assi H, Gartrell BA, Sankin A, Rodriguez-Vida A, Lythgoe M, Pinato DJ, Drakaki A, Joshi M, Isaacsson Velho P, Hahn N, Liu S, Alonso Buznego L, Duran I, Moses M, Jain J, Murgic J, Baratam P, Barata P, Tripathi A, Zakharia Y, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P. Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors. Cancer. 2020 03 15; 126(6):1208-1216. PMID: [31829450](//www.ncbi.nlm.nih.gov/pubmed/31829450); PMCID: [PMC7050422](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7050422).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31829450/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  37. **Li A** , Wu Q, Warnick G, Li S, Libby EN, Garcia DA, Lyman GH. The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma. Ann Hematol. 2020 Jan; 99(1):121-126. PMID: [31773215](//www.ncbi.nlm.nih.gov/pubmed/31773215).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31773215/citedby/) Fields:

Hem Hematology

Translation:HumansCTClinical Trials

  38. Starr MC, Wightman A, Munshi R, **Li A** , Hingorani S. Association of Food Insecurity and Acute Health Care Utilization in Children With End-stage Kidney Disease. JAMA Pediatr. 2019 Nov 01; 173(11):1097-1099. PMID: [31498384](//www.ncbi.nlm.nih.gov/pubmed/31498384); PMCID: [PMC6735494](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6735494).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31498384/citedby/) Fields:

Ped Pediatrics

  39. Shadman M, Gauthier J, Hay KA, Voutsinas JM, Milano F, **Li A** , Hirayama AV, Sorror ML, Cherian S, Chen X, Cassaday RD, Till BG, Gopal AK, Sandmaier BM, Maloney DG, Turtle CJ. Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy. Blood Adv. 2019 10 22; 3(20):3062-3069. PMID: [31648329](//www.ncbi.nlm.nih.gov/pubmed/31648329); PMCID: [PMC6849954](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6849954).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31648329/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  40. **Li A** , Kuderer NM, Garcia DA, Khorana AA, Wells PS, Carrier M, Lyman GH. Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysis. J Thromb Haemost. 2019 12; 17(12):2141-2151. PMID: [31420937](//www.ncbi.nlm.nih.gov/pubmed/31420937).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31420937/citedby/) Fields:

Hem Hematology

Translation:Humans

  41. Butt JH, **Li A** , Xian Y, Peterson ED, Garcia D, Torp-Pedersen C, K?ber L, Fosb?l EL. Direct oral anticoagulant- versus vitamin K antagonist-related gastrointestinal bleeding: Insights from a nationwide cohort. Am Heart J. 2019 10; 216:117-124. PMID: [31425898](//www.ncbi.nlm.nih.gov/pubmed/31425898).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31425898/citedby/) Fields:

Car Cardiology

Translation:Humans

  42. **Li A** , Wu Q, Luo S, Warnick GS, Zakai NA, Libby EN, Gage BF, Garcia DA, Lyman GH, Sanfilippo KM. Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma. J Natl Compr Canc Netw. 2019 07 01; 17(7):840-847. PMID: [31319391](//www.ncbi.nlm.nih.gov/pubmed/31319391); PMCID: [PMC7808759](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7808759).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31319391/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  43. **Li A** , Garcia DA. Review: The quality of evidence is very low for periprocedural bridging in patients receiving VKA for VTE. Ann Intern Med. 2019 06 18; 170(12):JC64. PMID: [31207617](//www.ncbi.nlm.nih.gov/pubmed/31207617).

Citations:  Fields:

Int Internal Medicine

Translation:Humans

  44. Khalighi PR, Martens KL, White AA, Li S, Silgard E, Frieze D, Garcia DA, **Li A**. Utilization patterns and clinical outcomes of rasburicase administration according to tumor risk stratification. J Oncol Pharm Pract. 2020 Apr; 26(3):529-535. PMID: [31167612](//www.ncbi.nlm.nih.gov/pubmed/31167612).

Citations:  Fields:

Neo NeoplasmsPha Pharmacy

Translation:Humans

  45. **Li A** , Manohar PM, Garcia DA, Lyman GH, Steuten LM. Cost effectiveness analysis of direct oral anticoagulant (DOAC) versus dalteparin for the treatment of cancer associated thrombosis (CAT) in the United States. Thromb Res. 2019 Aug; 180:37-42. PMID: [31200341](//www.ncbi.nlm.nih.gov/pubmed/31200341); PMCID: [PMC6661186](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6661186).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31200341/citedby/) Fields:

Vas Vascular Diseases

Translation:Humans

  46. Sun L, Mack J, **Li A** , Ryu J, Upadhyay VA, Uhl L, Kaufman RM, Stowell CP, Dzik WS, Makar RS, Bendapudi PK. Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura. Blood Adv. 2019 05 14; 3(9):1512-1518. PMID: [31076407](//www.ncbi.nlm.nih.gov/pubmed/31076407); PMCID: [PMC6517661](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6517661).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31076407/citedby/) Fields:

Hem Hematology

Translation:Humans

  47. Tuazon SA, **Li A** , Gooley T, Eunson TW, Maloney DG, Turtle CJ, Linenberger ML, Connelly-Smith LS. Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-cell malignancies. Transfusion. 2019 05; 59(5):1773-1780. PMID: [30729531](//www.ncbi.nlm.nih.gov/pubmed/30729531); PMCID: [PMC6499685](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6499685).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30729531/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  48. **Li A** , Wu Q, Davis C, Kirtane KS, Pham PD, Sorror ML, Lee SJ, Gopal AK, Dong JF, Garcia DA, Weiss NS, R Hingorani S. Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal. Biol Blood Marrow Transplant. 2019 03; 25(3):570-576. PMID: [30940363](//www.ncbi.nlm.nih.gov/pubmed/30940363); PMCID: [PMC6450411](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6450411).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30940363/citedby/) Fields:

Hem HematologyTra Transplantation

Translation:Humans

  49. Wang TF, **Li A** , Garcia D. Managing thrombosis in cancer patients. Res Pract Thromb Haemost. 2018 Jul; 2(3):429-438. PMID: [30046747](//www.ncbi.nlm.nih.gov/pubmed/30046747); PMCID: [PMC6046582](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6046582).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30046747/citedby/)

  50. **Li A** , Garcia DA, Lyman GH, Carrier M. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis. Thromb Res. 2019 01; 173:158-163. PMID: [29506866](//www.ncbi.nlm.nih.gov/pubmed/29506866); PMCID: [PMC6119655](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6119655).

Citations:
[71](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29506866/citedby/) Fields:

Vas Vascular Diseases

Translation:HumansPHPublic Health

  51. **Li A** , Khalighi PR, Wu Q, Garcia DA. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment. J Thromb Haemost. 2018 01; 16(1):164-169. PMID: [29064619](//www.ncbi.nlm.nih.gov/pubmed/29064619); PMCID: [PMC5760324](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5760324).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29064619/citedby/) Fields:

Hem Hematology

Translation:Humans

  52. **Li A** , Bendapudi PK, Uhl L, Hamdan A, Kaufman RM, Makar RS. Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency. Transfusion. 2017 09; 57(9):2151-2158. PMID: [28635017](//www.ncbi.nlm.nih.gov/pubmed/28635017).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28635017/citedby/) Fields:

Hem Hematology

Translation:Humans

  53. Boonyawat K, Caron F, **Li A** , Chai-Adisaksopha C, Lim W, Iorio A, Lopes RD, Garcia D, Crowther MA. Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis. J Thromb Haemost. 2017 07; 15(7):1322-1333. PMID: [28407368](//www.ncbi.nlm.nih.gov/pubmed/28407368).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28407368/citedby/) Fields:

Hem Hematology

Translation:Humans

  54. **Li A** , Davis C, Wu Q, Li S, Kesten MF, Holmberg LA, Gopal AK, Garcia DA. Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation. Blood Adv. 2017 May 09; 1(12):707-714. PMID: [29296714](//www.ncbi.nlm.nih.gov/pubmed/29296714); PMCID: [PMC5728057](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5728057).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29296714/citedby/) Fields:

Hem Hematology

  55. Bendapudi PK, Hurwitz S, Fry A, Marques MB, Waldo SW, **Li A** , Sun L, Upadhyay V, Hamdan A, Brunner AM, Gansner JM, Viswanathan S, Kaufman RM, Uhl L, Stowell CP, Dzik WH, Makar RS. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol. 2017 Apr; 4(4):e157-e164. PMID: [28259520](//www.ncbi.nlm.nih.gov/pubmed/28259520).

Citations:
[99](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28259520/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  56. **Li A** , Lopes RD, Garcia DA. Use of Direct Oral Anticoagulants in Special Populations. Hematol Oncol Clin North Am. 2016 10; 30(5):1053-71. PMID: [27637307](//www.ncbi.nlm.nih.gov/pubmed/27637307).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27637307/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  57. **Li A** , Makar RS, Hurwitz S, Uhl L, Kaufman RM, Stowell CP, Dzik WS, Bendapudi PK. Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study. Transfusion. 2016 08; 56(8):2069-77. PMID: [27232383](//www.ncbi.nlm.nih.gov/pubmed/27232383).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27232383/citedby/) Fields:

Hem Hematology

Translation:Humans

  58. **Li A** , [Yellapragada SV](https://profiles.viictr.org/profile/267994), Mims M, Frolov A, Rivero GA. Significant improvement in overall survival among patients diagnosed with low-risk myelodysplastic syndrome treated with selective serotonin reuptake inhibitors. Br J Haematol. 2017 04; 177(1):142-144. PMID: [27061100](//www.ncbi.nlm.nih.gov/pubmed/27061100).

Citations:  Fields:

Hem Hematology

Translation:Humans

  59. Bendapudi PK, **Li A** , Hamdan A, Uhl L, Kaufman R, Stowell C, Dzik W, Makar RS. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative. Br J Haematol. 2015 Dec; 171(5):836-44. PMID: [26314936](//www.ncbi.nlm.nih.gov/pubmed/26314936).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26314936/citedby/) Fields:

Hem Hematology

Translation:Humans

  60. Marshall A, **Li A** , Drucker A, Dzik W. Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series. Hematol Oncol. 2016 Sep; 34(3):147-53. PMID: [25641349](//www.ncbi.nlm.nih.gov/pubmed/25641349).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25641349/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 60 publications over 10 distinct years, with a maximum of
12 publications in
2019](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|12&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,25,42,25,100,67,75,33,83,33&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2015| 2  
2016| 3  
2017| 5  
2018| 3  
2019| 12  
2020| 8  
2021| 9  
2022| 4  
2023| 10  
2024| 4  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

LI's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (168)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Venous Thromboembolism](https://profiles.viictr.org/profile/252257)
  * [Thrombotic Microangiopathies](https://profiles.viictr.org/profile/249828)
  * [Anticoagulants](https://profiles.viictr.org/profile/255191)
  * [Venous Thrombosis](https://profiles.viictr.org/profile/250966)
  * [Pulmonary Embolism](https://profiles.viictr.org/profile/250066)

[Explore](https://profiles.viictr.org/profile/29964662/198)

_

Co-Authors (25)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [AMOS, CHRIS](https://profiles.viictr.org/profile/23372697)
  * [Ma, Shengling](https://profiles.viictr.org/profile/39339169)
  * [ROJAS HERNANDEZ, CRISTHIAM MAURICIO](https://profiles.viictr.org/profile/17440088)
  * [SARTAIN, SARAH](https://profiles.viictr.org/profile/3009824)
  * [KEBRIAEI, PARTOW](https://profiles.viictr.org/profile/12582909)

[Explore](https://profiles.viictr.org/profile/29964662/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [BRUERA, EDUARDO](https://profiles.viictr.org/profile/12582968)
  * [OO, THEIN HLAING](https://profiles.viictr.org/profile/12583936)
  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [CHAMPLIN, RICHARD E](https://profiles.viictr.org/profile/12582508)
  * [PEACOCK, WILLIAM](https://profiles.viictr.org/profile/268773)

[Explore](https://profiles.viictr.org/profile/29964662/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [CHANG, JENNY](https://profiles.viictr.org/profile/269169)
  * [LYNCH, GARRETT](https://profiles.viictr.org/profile/269644)
  * [RIMAWI, MOTHAFFAR](https://profiles.viictr.org/profile/269416)
  * [SEARS, DAVID](https://profiles.viictr.org/profile/267960)
  * [SONNET, CORINNE](https://profiles.viictr.org/profile/15317746)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

